On Nov. 13, Ocera Therapeutics, Inc. (NASDAQ:OCRX) announced recent business highlights and reported financial results for the quarter ended September 30, 2014. As of September 30, 2014, Ocera had cash, cash equivalents and investments of $55.6 million. Net loss for the three and nine months ended September 30, 2014 was $6.6 million and $17.9 million, respectively. Ocera Therapeutics, Inc. (NASDAQ:OCRX) belongs to Healthcare sector. Its … Continue reading Eye Catching Stocks: Ocera Therapeutics, Inc. (NASDAQ:OCRX), Groupon, Inc. (NASDAQ:GRPN), Renewable Energy Group, Inc. (NASDAQ:REGI), Natural Alternatives International (NASDAQ:NAII), TD Ameritrade (NYSE:AMTD)